The pharma company has agreed to divest two oral solid dosage manufacturing facilities to Frontida BioPharma.
Sun Pharma gained 1% to Rs.746 after the pharma company announced that as a part of its manufacturing consolidation in the US, one of its wholly owned subsidiaries has entered into an agreement with Frontida BioPharma.
The scrip opened at Rs. 750 and has touched a high and low of Rs. 750.25 and Rs. 740.4 respectively. So far 323535(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 177678.61 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 965.15 on 20-Aug-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 842.05 and Rs. 735.3 respectively.
The promoters holding in the company stood at 54.97 % while Institutions and Non-Institutions held 35.37 % and 9.65 % respectively.
Sun Pharma gained 1% to Rs.746 after the pharma company announced that as a part of its manufacturing consolidation in the US, one of its wholly owned subsidiaries has entered into an agreement with Frontida BioPharma. The scrip opened at Rs. 750 and has touched a high and low of Rs. 750.25 and Rs. 740.4 respectively. So far 323535(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 177678.61 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 965.15 on 20-Aug-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 842.05 and Rs. 735.3 respectively.
The promoters holding in the company stood at 54.97 % while Institutions and Non-Institutions held 35.37 % and 9.65 % respectively.
No comments:
Post a Comment